These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29769997)

  • 1. Updates to the
    Jensen C; Lerch R;
    Can Commun Dis Rep; 2016 Dec; 42(12):256-259. PubMed ID: 29769997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule.
    Tunis MC; Deeks SL;
    Can Commun Dis Rep; 2016 Jul; 42(7):149-151. PubMed ID: 29770021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of the National Advisory Committee on Immunization's Statement on the re-immunization with polysaccharide 23-valent pneumococcal vaccine.
    Quach C;
    Can Commun Dis Rep; 2015 Apr; 41(Suppl 3):14-16. PubMed ID: 29769962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New vaccine administration practice recommendations from the
    Jensen C; Moore D; Mah C; Baclic O; Marchant-Short S;
    Can Commun Dis Rep; 2017 Nov; 43(11):242-244. PubMed ID: 29770054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2016-2017.
    Gemmill I; Zhao L; Cochrane L;
    Can Commun Dis Rep; 2016 Sep; 42(9):188-192. PubMed ID: 29770030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is new in the Canadian Immunization Guide: November 2016 to November 2018.
    Fleurant-Ceelen A; Tunis M; House A
    Can Commun Dis Rep; 2018 Dec; 44(12):331-335. PubMed ID: 31517951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations.
    Deeks SL; Tunis MC; Ismail S;
    Can Commun Dis Rep; 2017 Jun; 43(6):138-142. PubMed ID: 29770079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2015-2016.
    Gemmill I;
    Can Commun Dis Rep; 2015 Oct; 41(10):227-232. PubMed ID: 29769917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of the NACI Statement on Public Health Level Recommendations on the Use of Pneumococcal Vaccines in Adults, Including the Use of 15-valent and 20-valent Conjugate Vaccines.
    Wierzbowski A; Pless R; Hildebrand KJ
    Can Commun Dis Rep; 2023 Feb; 49(23):81-86. PubMed ID: 38088953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates to the
    Gemmill I; Quach C;
    Can Commun Dis Rep; 2015 Apr; 41(Suppl 3):19-21. PubMed ID: 29769964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022-2023.
    Sinilaite A; Papenburg J
    Can Commun Dis Rep; 2022 Sep; 48(9):373-382. PubMed ID: 38116046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
    Grohskopf LA; Blanton LH; Ferdinands JM; Chung JR; Broder KR; Talbot HK; Morgan RL; Fry AM
    MMWR Recomm Rep; 2022 Aug; 71(1):1-28. PubMed ID: 36006864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
    Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
    MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of the National Advisory Committee on Immunization's Update on the recommended human papillomavirus (HPV) vaccine immunization schedule.
    Ismail S; Deeks S;
    Can Commun Dis Rep; 2015 Apr; 41(Suppl 3):11-13. PubMed ID: 29769961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017-2018.
    Vaudry W; Stirling R;
    Can Commun Dis Rep; 2017 May; 43(5):96-103. PubMed ID: 29770072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary of the NACI Seasonal Influenza Vaccine Statement for 2020-2021.
    Young K; Gemmill I; Harrison R
    Can Commun Dis Rep; 2020 May; 46(5):132-137. PubMed ID: 32558810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of NACI Statement: Interim Recommendations on the Use of Pneumococcal Vaccines in Immunocompetent Adults 65 Years of Age and Older.
    Quach C; Baclic O;
    Can Commun Dis Rep; 2016 Dec; 42(12):260-262. PubMed ID: 29769998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of the NACI Seasonal Influenza Vaccine Statement for 2018-2019.
    Vaudry W; Zhao L; Stirling R
    Can Commun Dis Rep; 2018 Jun; 44(6):123-128. PubMed ID: 31015804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.